Home
Conditions
Respiratory Tract Diseases

Clinical trial condition

Respiratory Tract Diseases

Explore clinical trials studying Respiratory Tract Diseases. Study availability and eligibility vary by location and protocol.

37,319 public trials 4,954 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Diseases trial results

Recruiting

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

NCT06992440

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations: The Johns Hopkins Hospital Baltimore, Maryland, United States

Cleveland Clinic Cleveland, Ohio, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Recruiting

Investigating the Impact of Early Time-Restricted Eating on Health Outcomes and Quality of Life in Adults With Mild Controlled Asthma Compared to Healthy Adults

NCT07345572

Conditions: Asthma, Asthma Management, Behavior, +12 more
Locations: Health and Life Science Leicester, England, United Kingdom

View Trial Details

Recruiting

To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy

NCT04853342

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

NCT06956001

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Ethics Committee of cancer hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Shandong Tumor Hospital Shandong, Jinan, China

View Trial Details

Recruiting

Taurine Supplementation in Long COVID

NCT06721949

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +16 more
Locations: University of Alberta Hospital, Kaye Edmonton Clinic Edmonton, Alberta, Canada

BC Women's Hospital Vancouver, British Columbia, Canada

University Health Network Toronto, Ontario, Canada

Institut de recherches cliniques de Montréal Montreal, Quebec, Canada

View Trial Details

Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +13 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

University of California San Francisco San Francisco, California, United States

Barbara Davis Center for Diabetes Young Adult Clinic Aurora, Colorado, United States

Yale University New Haven, Connecticut, United States

View Trial Details

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06955988

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

NCT06228066

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, High Grade Neuroendocrine Tumors of the Urinary Tract, +9 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

NCT05288205

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +31 more
Locations: The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China

Pecking Union Medical College Hospital Beijing, Beijing Municipality, China

Cancer Hospital Chinese Academy Of Medical Sciences Beijing, Beijing Municipality, China

Beijing Tiantan Hospital, Captal Medical University Beijing, Beijing Municipality, China

View all 27 locations

View Trial Details

Recruiting

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT07234032

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +6 more
Locations: USA006 Naples, Florida, United States

USA003 Bend, Oregon, United States

JPN004 Narita, Chiba, Japan

KOR001 Seoul, South Korea

View Trial Details

Respiratory Tract Diseases

Respiratory Tract Diseases trial results

Related conditions